Enveric Biosciences
(NASDAQ) ENVB
Enveric Biosciences Financials at a Glance
Market Cap
$3.83M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.77M
EPS (TTM)
$-40.85
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Price
$2.01
Volume
4,259
Open
$2.03
Price
$2.01
Volume
4,259
Open
$2.03
Previous Close
$2.01
Daily Range
$1.96 - $2.04
52-Week Range
$1.75 - $17.84
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Price
$2.01
Volume
4,259
Open
$2.03
Previous Close
$2.01
Daily Range
$1.96 - $2.04
52-Week Range
$1.75 - $17.84
ENVB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Enveric Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
6
CEO
Joseph Tucker, PhD
Website
www.enveric.comHeadquarters
Naples, FL 34103, US
ENVB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-304%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
-21.04%
Stock Overview
Market Cap
$3.83M
Shares Outstanding
1.89M
Volume
4.26K
Short Interest
0.00%
Avg. Volume
357.11K
Financials (TTM)
Gross Profit
$200.86K
Operating Income
$8.77M
EBITDA
$8.57M
Operating Cash Flow
$8.14M
Capital Expenditure
$3.00
Free Cash Flow
$8.14M
Cash & ST Invst.
$4.68M
Total Debt
$0.00
Enveric Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$39.48K
+52.1%
Gross Margin
0.00%
N/A
Market Cap
$3.83M
N/A
Market Cap/Employee
$766.34K
N/A
Employees
5
N/A
Net Income
$2.19M
+30.4%
EBITDA
$2.15M
+29.7%
Quarterly Fundamentals
Net Cash
$4.68M
+108.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.72%
N/A
Return on Invested Capital
-2.10%
N/A
Free Cash Flow
$1.78M
-36.1%
Operating Cash Flow
$1.78M
-36.1%